Oscar Health

OSCR

Market cap $4.92B

NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. 2025 Fourth Quarter and Full Year Earnings Conference Call.

Oscar Health is delivering A-grade growth with ~37% YoY revenue expansion and roughly 30% forward topline growth visibility. Management plans a disciplined ~28% weighted average rate increase in 2026 to directly address margins and profitability. Shares remain largely flat since prior coverage, creating a mispricing despite improving fundamentals and clearer strategic execution.

Oscar Health, Inc. (OSCR) reached $16.9 at the closing of the latest trading day, reflecting a +2.55% change compared to its last close.

Oscar Health, Inc. (OSCR) concluded the recent trading session at $14.84, signifying a -1.26% move from its prior day's close.

Shares of Coupang and Oscar Health have good chances of bouncing back in 2026. Improved profit margins for the e-commerce giant should continue into 2026.

In this video, I will discuss two undervalued companies that have experienced a decent pullback in 2025 and expect to show fundamental improvements in 2026. Watch the short video to learn more, consider subscribing, and click the special offer link below.

Oscar Health, Inc. (OSCR) reached $15.71 at the closing of the latest trading day, reflecting a -2.66% change compared to its last close.

From a technical perspective, Oscar Health, Inc. (OSCR) is looking like an interesting pick, as it just reached a key level of support. OSCR recently overtook the 200-day moving average, and this suggests a long-term bullish trend.

The latest trading day saw Oscar Health, Inc. (OSCR) settling at $15.59, representing a -8.08% change from its previous close.

Oscar Health's (OSCR +1.31%) management team is planning big price increases in 2026 to offset higher costs.